CALC CALCIMEDICA INC revenue, earnings and financials
For the quarter ended June 30, 2026, CALCIMEDICA INC reported revenue of n/a, net income of −$7.65M and diluted EPS of −$0.45; for the fiscal year ended December 2025 revenue was n/a.
CALC annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$23.1M, net income −$29.6M (margin n/a), EPS −$1.97
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$24.2M, net income −$13.7M (margin n/a), EPS −$1.22
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$38.1M, net income −$34.4M (margin n/a), EPS −$7.66
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$14.2M, net income −$7.82M (margin n/a), EPS −$111.16
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$35.9M, net income −$35.8M (margin n/a), EPS −$1.69
CALC quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$7.65M, EPS −$0.45
- Quarter ended Mar 31, 2026: revenue n/a, net income $4.98M, EPS $0.30
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$10.8M, EPS −$0.69
- Quarter ended Sep 30, 2025: revenue n/a, net income −$7.80M, EPS −$0.52
- Quarter ended Jun 30, 2025: revenue n/a, net income −$5.96M, EPS −$0.40
- Quarter ended Mar 31, 2025: revenue n/a, net income −$5.04M, EPS −$0.36
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$4.26M, EPS −$0.37
- Quarter ended Sep 30, 2024: revenue n/a, net income −$5.62M, EPS −$0.50
- Quarter ended Jun 30, 2024: revenue n/a, net income −$3.95M, EPS −$0.36
- Quarter ended Mar 31, 2024: revenue n/a, net income $130K, EPS $0.01
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$4.15M, EPS $17.70
- Quarter ended Sep 30, 2023: revenue n/a, net income −$4.62M, EPS −$0.82
- Quarter ended Jun 30, 2023: revenue n/a, net income −$6.30M, EPS −$1.11
- Quarter ended Mar 31, 2023: revenue n/a, net income −$19.3M, EPS −$23.43
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income $1.42M, EPS $2.56
- Quarter ended Sep 30, 2022: revenue n/a, net income −$2.58M, EPS −$31.04
- Quarter ended Jun 30, 2022: revenue n/a, net income −$3.03M, EPS −$36.55
- Quarter ended Mar 31, 2022: revenue n/a, net income −$3.63M, EPS −$46.13
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$8.68M, EPS −$0.41
- Quarter ended Sep 30, 2021: revenue n/a, net income −$7.99M, EPS −$0.38
CALC cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$21.2M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$21.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$25.7M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$11.8M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$31.5M, share buybacks n/a
CALC balance sheet
- Jun 30, 2026: cash $18.6M, total assets $19.5M, total liabilities $14.0M, shareholders' equity $5.51M
- Mar 31, 2026: cash $8.16M, total assets $8.61M, total liabilities $9.71M, shareholders' equity −$1.10M
- Dec 31, 2025: cash $11.5M, total assets $13.6M, total liabilities $20.2M, shareholders' equity −$6.64M
- Sep 30, 2025: cash $5.47M, total assets $14.9M, total liabilities $15.2M, shareholders' equity −$268K
- Jun 30, 2025: cash $5.92M, total assets $19.1M, total liabilities $13.0M, shareholders' equity $6.10M
- Mar 31, 2025: cash $12.6M, total assets $25.3M, total liabilities $14.5M, shareholders' equity $10.9M
- Dec 31, 2024: cash $7.94M, total assets $19.8M, total liabilities $5.38M, shareholders' equity $14.4M
- Sep 30, 2024: cash $9.15M, total assets $16.2M, total liabilities $7.18M, shareholders' equity $9.03M
Is CALC profitable?
No. CALCIMEDICA INC lost $21.2M over the last four quarters.
What is CALC's EPS?
Diluted earnings per share over the last four quarters were −$1.36; −$0.45 in the latest quarter.